SD HEALTHCARERecent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...
San Diego-based Aethlon Medical Inc., a company developing targeted therapeutic devices to address infectious diseases and cancer, announced that its majority-owned subsidiary Exosome Sciences Inc. has entered into a research collaboration with Thomas Jefferson University.April 3, 2015 1:04 p.m. Share
BIOTECH: Rapid Results in the OR Should Reduce Re-Excision Rate
A device now being used at Sharp Memorial Hospital is helping surgeons more thoroughly remove cancerous tissue during breast cancer surgery, reducing the need for follow-up procedures and providing a better chance for patients to recover.
BIOTECH: Huge Data Sets to Get Rapid and Cost-Effective Analysis
Edico Genome Inc., a La Jolla-based tech startup, announced that it’s collaborating with Intel Corp. to speed up next-generation genome sequencing (NGS) data analysis.
San Diego-based Ligand Pharmaceuticals Inc. announced the appointment of Melanie Herman as interim chief financial officer, effective May 21.
ResMed Inc., a company that makes medical devices for sleep-related disorders, reported net income of about $91 million on net revenue of $422.5 million for the third quarter that ended March 31.
San Diego-based biotechnology firm Illumina Inc. posted a strong first quarter in 2015, reporting a 28 percent growth in revenue year over year.
Edico Genome Inc., a La Jolla-based tech startup, announced Tuesday that it’s collaborating with Intel Corp. to speed up next-generation sequencing data analysis.
GlycoRegImmune Inc. (GRI Bio), a biotech developing treatments for inflammatory disease, recently raised $4.38 million in equity financing, according to a recent regulatory filing.
DJO Global Inc., a medical device company in San Diego, announced Monday the financial results for its public reporting subsidiary, DJO Finance LLC, for the 2015 first quarter.
La Mesa-based Regen BioPharma Inc. announced that it added three internationally renowned cancer stem cell experts to its scientific advisory board.
Trovagene Inc., a cell-free molecular diagnostic company, announced that recent clinical data showed its urine-based Precision Cancer Monitoring platform outperformed traditional tissue biopsy for the detection and monitoring of specific mutations in metastatic lung cancer patients.
MediciNova, Inc., a biopharmaceutical company, announced that it has received Fast Track designation from the U.S. Food and Drug Administration for MN-001 (tipelukast) for the treatment of patients with nonalcoholic steatohepatitis (NASH) with fibrosis.
Avelas Biosciences Inc., a cancer diagnostic company focused on improving cancer surgeries, announced Thursday that it has started a Phase 1b study of its lead fluorescent cancer illuminator, AVB-620, in women with primary non-recurrent breast cancer.
Receptos Inc. stock was up 5 percent Thursday morning following the company’s announcement regarding its lead product candidate ozanimod.
Aethlon Medical Inc., a medical device company developing therapies for infectious diseases and cancer, announced that it has entered into a clinical trial agreement with the University of California, Irvine.
Irvine-based LAG Fit Inc. has acquired Club Pilates, a franchised chain of 35 Pilates studios in the U.S. and Australia.